No Data
Hims & Hers Health Is Maintained at Buy by TD Cowen
Hims & Hers Health Is Maintained at Buy by TD
Hims & Hers Health Price Target Raised to $25.00/Share From $15.00 by TD Cowen
Hims & Hers Health Price Target Raised to $25.00/Share From $15.00 by TD
Piper Sandler Adjusts Price Target on Hims & Hers Health to $18 From $16, Maintains Neutral Rating
Hims & Hers Health (HIMS) has an average outperform rating and price target range of $13 to $26, according to analysts polled by Capital IQ.Price: 21.01, Change: +0.80, Percent Change: +3.96
Hims & Hers Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/11/2024 -11.11% Piper Sandler $16 → $18 Maintains Neutral 06/27/2024 13.58% Jefferies $14 → $23
Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)
TD Cowen Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $25
TD Cowen analyst Jonna Kim maintains $Hims & Hers Health(HIMS.US)$ with a buy rating, and adjusts the target price from $15 to $25.According to TipRanks data, the analyst has a success rate of 53.3%